Pediatrix Medical (MD) Cash from Investing Activities (2009 - 2026)

Pediatrix Medical has disclosed Cash from Investing Activities across 18 years of filings, most recently posting -$12.0 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 60.49% year-over-year to -$12.0 million; the TTM figure through Mar 2026 stood at -$22.8 million (up 14.35% YoY), while the FY2025 annual figure was -$18.3 million, up 48.33% from the prior year.
• Cash from Investing Activities eased to -$12.0 million in Q1 2026, from -$10.3 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for MD reached as high as $6.6 million in Q3 2025 and fell as low as -$26.3 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is -$11.2 million (2022), against an average of -$10.0 million.
• The widest YoY moves for Cash from Investing Activities: up 252.24% in 2025, down 430.55% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at -$11.2 million in 2022, then declined by 10.52% to -$12.4 million in 2023, then surged by 84.4% to -$1.9 million in 2024, then sank by 430.55% to -$10.3 million in 2025, then decreased by 16.5% to -$12.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$12.0 million, -$10.3 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.